Gynecological malignancies, including ovarian, endometrial (uterine), and cervical cancers, represent a substantial global health burden. Cervical cancer ...

BioLabs (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today provided an ...

Baseline LDH as a prognostic biomarker of early treatment failure in lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...

Multicentric evaluation of an artificial intelligence model to stratify stage II colon cancer patients from whole slide images.

Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects ...

What if people could detect cancer and other diseases with the same speed and ease of a pregnancy test or blood glucose meter? Researchers at the Carl R. Woese Institute for Genomic Biology are a step ...

Cervical cancer remains a major health threat for women globally, with the highest incidence in developing nations. Despite the availability of preventive measures, challenges such as limited ...

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced four strategic additions to its executive leadership team: Jeff ...